filings.toolsItem 6. SELECTED FINANCIAL DATA.
4K characters. Original on sec.gov · Markdown
Item 6. SELECTED FINANCIAL DATA.
The following table sets forth our selected historical consolidated financial information for each of the five periods indicated. This information should be read together with “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and with the consolidated financial statements and related notes included elsewhere in this 2019 Form 10-K including disclosures related to the November 20, 2019 acquisition of Celgene.
The selected historical financial information as of and for the years ended December 31, 2019, 2018, 2017, 2016 and 2015 are derived from our audited consolidated financial statements and related notes.
Five Year Financial Summary
| Amounts in Millions, except per share data | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||||
| Income Statement Data: | |||||||||||||||||||
| Total Revenues | $ | 26,145 | $ | 22,561 | $ | 20,776 | $ | 19,427 | $ | 16,560 | |||||||||
| Net Earnings | 3,460 | 4,947 | 975 | 4,507 | 1,631 | ||||||||||||||
| Net Earnings/(Loss) Attributable to: | |||||||||||||||||||
| Noncontrolling Interest | 21 | 27 | (32 | ) | 50 | 66 | |||||||||||||
| BMS | 3,439 | 4,920 | 1,007 | 4,457 | 1,565 | ||||||||||||||
| Net Earnings per Common Share Attributable to BMS: | |||||||||||||||||||
| Basic | $ | 2.02 | $ | 3.01 | $ | 0.61 | $ | 2.67 | $ | 0.94 | |||||||||
| Diluted | 2.01 | 3.01 | 0.61 | 2.65 | 0.93 | ||||||||||||||
| Weighted average common shares outstanding: | |||||||||||||||||||
| Basic | 1,705 | 1,633 | 1,645 | 1,671 | 1,667 | ||||||||||||||
| Diluted | 1,712 | 1,637 | 1,652 | 1,680 | 1,679 | ||||||||||||||
| Cash dividends paid on BMS common and preferred stock | $ | 2,679 | $ | 2,613 | $ | 2,577 | $ | 2,547 | $ | 2,477 | |||||||||
| Cash dividends declared per common share | $ | 1.68 | $ | 1.61 | $ | 1.57 | $ | 1.53 | $ | 1.49 | |||||||||
| Financial Position Data at December 31: | |||||||||||||||||||
| Cash and cash equivalents | $ | 12,346 | $ | 6,911 | $ | 5,421 | $ | 4,237 | $ | 2,385 | |||||||||
| Marketable debt securities(a)(b) | 3,814 | 3,623 | 3,739 | 4,724 | 6,442 | ||||||||||||||
| Total Assets | 129,944 | 34,986 | 33,551 | 33,707 | 31,748 | ||||||||||||||
| Long-term debt(a) | 46,150 | 6,895 | 6,975 | 6,465 | 6,550 | ||||||||||||||
| Equity | 51,698 | 14,127 | 11,847 | 16,347 | 14,424 |
| (a) | Includes current and non-current portion. |
| (b) | Prior period amounts were conformed to current period presentation. |
Previous: Item 5. MARKET FOR THE REGISTRANT’S COMMON STOCK AND OTHER STOCKHOLDER MATTERS. · Next: Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.